Articles and Information
Form 7 Monthly Progress Report August 2024
Form 7 Monthly Progress Report Sept 2024 Name of Listed Issuer: Trading Symbol: Number of
September 1, 2024
- News
BioMark Diagnostics Announces Progress in Assay Validation for Clinical Sample Analysis
BioMark Diagnostics Inc.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Categories
Archives
Sign up for the latest Biomark news
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Related articles ...
Articles and Information
Form 7 Monthly Progress Report July 2024
Form 7 Monthly Progress Report July 2024 Name of Listed Issuer: Trading Symbol: Number of
August 4, 2024
News
The U.S. Patent and Trademark Office Grants BIOMARK PATENT THAT EXPANDS ITS CLAIMS COVERING ITS LEGACY LIQUID BIOPSY ASSAY
The U.S. Patent and Trademark Office Grants BIOMARK PATENT THAT EXPANDS ITS CLAIMS COVERING ITS
August 4, 2024
News
BioMark Diagnostics Announces Presentation of Promising Glioblastoma Research AT 2024 GPEN Conference
BioMark Diagnostics Announces Presentation of Promising Glioblastoma Research At 2024 GPEN Conference Vancouver, British Columbia
July 16, 2024
Articles and Information
Form 7 Monthly Progress Report June 2024
Form 7 Monthly Progress Report May 2024 Name of Listed Issuer: Trading Symbol: Number of
July 6, 2024
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2